Skip to site menu Skip to page content

Daily Newsletter

12 June 2023

Daily Newsletter

12 June 2023

India’s KIMS acquires Hiranandani Group’s hospital in Thane

KIMS is expected to soon make an announcement to the stock exchange regarding the transaction.

June 12 2023

India-based hospital chain Krishna Institute of Medical Sciences (KIMS) has acquired real estate developer Hiranandani Group’s newly constructed 200-bed hospital property in Thane, Maharashtra in a deal valued at Rs2.75bn ($33.35m).

Spanning about 30,000ft² within Thane's Hiranandani Estate, the hospital has held an occupation certificate for over a year and is nearly as large as the developer's hospital with 250 beds in Powai's Hiranandani complex.

KIMS is a corporate healthcare group specialising in tertiary care and operating hospitals in the states of Telangana, Andhra Pradesh, and Maharashtra.

As a publicly listed company, KIMS is expected to make an announcement to the stock exchange regarding this transaction, soon.

A source familiar with the details revealed that the Thane hospital marks KIMS' second acquisition, following its 51% stake purchase in Nagpur's Kingsway Hospital for Rs800m ($9.7m) last year.

The Mumbai market has been challenging for healthcare chains to enter due to the high real estate cost, resulting in a preference for acquiring existing hospitals rather than constructing new ones.

In the same way, the Manipal group is reportedly holding discussions for the acquisition of a 1,000-bed hospital currently under construction in Borivli.

Additionally, Thane's Jupiter Hospital will manage the 500-bed hospital of Lodha Group.

Uncover your next opportunity with expert reports

Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close